Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2019-07-08
DOI
10.1080/10428194.2019.1633633
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
- (2019) Shohei Mizuno et al. BONE MARROW TRANSPLANTATION
- Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients
- (2019) Thierry Facon et al. BLOOD
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
- (2019) Thierry Facon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melphalan-based autologous transplant in octogenarian multiple myeloma patients
- (2018) Neeraj Y. Saini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
- (2018) Guido Ghilardi et al. BONE MARROW TRANSPLANTATION
- Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
- (2017) Philip L. McCarthy et al. JOURNAL OF CLINICAL ONCOLOGY
- Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- (2017) Heather L. Koniarczyk et al. Seminars in Oncology Nursing
- Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy
- (2016) Jasmin Stettler et al. LEUKEMIA & LYMPHOMA
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
- (2014) Manish Sharma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
- (2014) H W Auner et al. BONE MARROW TRANSPLANTATION
- Multiple Myeloma in the Very Old: An IASIA Conference Report
- (2014) Sascha A. Tuchman et al. JNCI-Journal of the National Cancer Institute
- Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
- (2013) M. Merz et al. ANNALS OF ONCOLOGY
- How I assess comorbidities before hematopoietic cell transplantation
- (2013) M. L. Sorror BLOOD
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
- (2011) Qaiser Bashir et al. LEUKEMIA & LYMPHOMA
- Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
- (2010) Maria-Victoria Mateos et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
- (2008) Shaji K. Kumar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started